Xu Cong Claire — SEC Form 4 filings

SEC reporting owner CIK 2114309. 3 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2026-06-02 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NovaBridge Biosciences (NBP)EVP, Clinical Development33 legs · 11,261 sh · $20,3516

Form 4 filings — Xu Cong Claire

FiledFormIssuerReported transactionsSource
2026-09-014NovaBridge Biosciences (NBP)Option exercise (M): 9,382 · Sale (S): 3,282 @ $0.79 · Option exercise (M): 4,079 (derivative) @ $0EDGAR
2026-07-074NovaBridge Biosciences (NBP)Option exercise (M): 12,432 · Sale (S): 4,485 @ $0.89 · Option exercise (M): 5,405 (derivative) @ $0EDGAR
2026-06-024NovaBridge Biosciences (NBP)Option exercise (M): 9,382 · Sale (S): 3,494 @ $3.94 · Option exercise (M): 4,079 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2114309 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →